A research team at the VIB-KU Leuven Center for Microbiology has developed a novel screening method to identify antimicrobial properties of volatile substances. With this assay, they tested the vapour-phase-mediated activity of 175 essential oils (EOs) and 37 EO components. Approximately half of them proved active against the most drug-resistant type of Candida. In a context of fungi showing increasing drug resistance, these findings may be useful in both medical and agricultural applications.
The research project, led by prof. Patrick Van Dijck, is rooted in the growing problem of antifungal drug resistance. Candida cells, for example, are quickly becoming tolerant to fluconazole, the most-used antifungal drug. Next to exploring experimental new techniques, scientists also seek to repurpose existing substances. Plant essential oils (EOs), metabolites obtained by steam distillation or cold citrus peel pressing, may offer interesting opportunities: they are made up of compounds that help protect the plant against microbial or herbivore attacks.
Identifying EOs and their compounds
In the VIB-KU Leuven Center for Microbiology, Adam Feyaerts gathered a collection of 175 different EOs, constituting a collection of over one thousand different small molecules. The aim was to identify biologically active compounds present in these complex mixtures. They therefore developed a new class of assay that allowed to identify new volatile substances with antifungal activities over a distance.
Prof. Patrick Van Dijck (VIB-KU Leuven): “We screened our whole collection of EOs for vapor-phase mediated antifungal activity against two human fungal pathogens, Candida albicans and Candida glabrata. Interestingly, we found that approximately half of the EOs and their compounds had vapour-phase-mediated activity against bothCandida species. Surprisingly, C. glabrata, the most drug-resistant species of the two was on average even more susceptible. In contrast, none of the currently used antifungals showed any vapour-phase-mediated activity.”
Numerous potential applications
This is now the first simple test to look for the vapor-phase-mediated antimicrobial activity of molecules. The same assay could also be used to test other biological activity. And although these findings still have to be confirmed in clinical trials, potential applications are numerous.
Co-author Adam Feyaerts (VIB-KU Leuven): “Our findings are for instance a starting point for the development of molecules that could also be used in vaporizers. After all, volatiles can access otherwise hard to reach areas. Think of possibilities such as maintaining hygiene in hospitals or treat patients with lung infections. There are agricultural options too, such as preventing post-harvest contamination or protecting crops against pests.”
The Latest on: Antifungal drug resistance
via Google News
The Latest on: Antifungal drug resistance
- A Poetic, Mind-Bending Tour of the Fungal Worldon June 24, 2020 at 6:27 am
Fungal species count in the millions—the true number is unknown. And they serve as a platform for, and partner in, almost every aspect of life. No fungi, no us. Sheldrake’s book is a poetic letter to ...
- Drug-Resistant Bacteria Can Be Hidden Danger for People with COVID-19on June 23, 2020 at 3:08 pm
Nearly half of patients who’ve died from COVID-19 had a secondary bacterial infection. Sometimes, these secondary infections are resistant to antibiotics and antifungals, making them difficult and ...
- Study: Increased use of human antibiotics on rice crops may fuel antibiotic resistanceon June 23, 2020 at 7:15 am
Farmers in parts of Asia are spraying antibiotics deemed "critical" for human medicine on rice crops, raising fears they may be fuelling antibiotic resistance, say researchers.
- Significant CAGR Growth to Be Achieved by Antifungal Drugs Market Size by Global Trends, Size, Growth Rate by 2023on June 18, 2020 at 5:05 am
However, growing portfolio of antifungal generic drugs, patent expiration of innovator drugs, increasing prevalence of fungal resistance, and counterfeit drugs are expected to hinder the market ...
- Fighting the Coronavirus With Innovative Techon June 16, 2020 at 2:06 am
This article is part of Owning the Future, a series on how small businesses across the country are coping with the coronavirus pandemic. Dr. Cristiano Huscher has long used robotics and artificial ...
- Agricultural Research Scientists Honored for Their Federal Serviceon June 15, 2020 at 7:30 pm
Heather Allen and Jo Anne Crouch, both scientists with the Agricultural Research Service (ARS), have received the 2019 Arthur S. Flemming Award for their outstanding scientific achievements in the ...
- Fungal Endophthalmitison June 13, 2020 at 5:00 pm
These newer drugs have a broader antifungal spectrum ... immunosuppressive therapy and malignancies. The incidence of fungal endophthalmitis primarily depends upon the climate, more tropical ...
- Invasive Fungal Infection Market by Size, Growth, Opportunity and Forecast to 2025on June 11, 2020 at 10:01 pm
A number of companies are offering variety of antibiotics which have decreased the resistance of several medicines, thus increasing the incidence of invasive fungal infection. In ...
- Doctors heavily overprescribed antibiotics early in the pandemicon June 11, 2020 at 9:35 pm
With few treatment options, doctors turned to broad-spectrum antibiotics, the shot-in-the-dark medications often used against unidentified bacterial infections. They knew antibiotics are not effective ...
- Destiny Pharma awarded grant to fund collaboration with Cardiff University targeting fungal infectionson June 11, 2020 at 10:29 am
but successful treatment is hindered by biofilm resistance and a limited number of effective antifungal drugs. This project will evaluate the XF drug candidates in combatting Candida biofilms and ...
via Bing News